drachma
if you're talking about a hostile takeover, IMO that's not on the cards as management have massive holdings to resist such a move. I forget the figures but check out the MSB website and it's there.
Ilescu has a few clues about the vulnerability of australian biotechs in the past and has taken preventive measures.
Further, the 'deal of the year' 2010 between Cepahlon/now Teva and MSB was not awarded for no reason. Ilescu has a few clues.
IMO.
DV
- Forums
- ASX - By Stock
- MSB
- setting the record straight
setting the record straight, page-20
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.00 |
Change
-0.065(6.10%) |
Mkt cap ! $1.141B |
Open | High | Low | Value | Volume |
$1.04 | $1.04 | 99.5¢ | $3.281M | 3.243M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 23962 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 33833 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2881 | 1.005 |
18 | 96266 | 1.000 |
23 | 213975 | 0.995 |
17 | 105304 | 0.990 |
4 | 98693 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 54672 | 12 |
1.015 | 105748 | 13 |
1.020 | 99301 | 12 |
1.025 | 40418 | 5 |
1.030 | 122828 | 6 |
Last trade - 15.23pm 04/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |